Skinvisible SKVI
OTC SKVI
$0.20 -0.23 (-53.49%)
At close: Sep 4, 2026 · 4:00 PM EDT

Skinvisible (SKVI) Notes Payables (2012 - 2025)

Skinvisible's (SKVI) quarterly Notes Payables came in at $352075.0 in Q4 2025, little changed quarter-over-quarter from $352075.0 in Q3 2025.

Analysis

Skinvisible (SKVI) Notes Payables (2012 - 2025) Analysis & Trends

Skinvisible has disclosed Notes Payables across 14 years of filings, most recently posting $352075.0 for Q4 2025.

  • In Q4 2025, Notes Payables changed N/A year-over-year to $352075.0; the TTM figure through Dec 2025 stood at $352075.0 (changed N/A YoY), while the FY2025 annual figure was $352075.0, changed N/A from the prior year.
  • Notes Payables came in at $352075.0 for Q4 2025 at Skinvisible, roughly flat from $352075.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $3.0 million in Q4 2022 to a low of $40000.0 in Q1 2023.
  • Average Notes Payables over 5 years is $1.2 million, with a median of $388948.0 recorded in 2024.
  • Year-over-year, Notes Payables surged 1658.77% in 2021 and sank 98.66% in 2023.
  • Over 5 years, Notes Payables stood at $2.4 million in 2021, then rose by 25.6% to $3.0 million in 2022, then slumped by 98.66% to $40000.0 in 2023, then soared by 904.4% to $401761.0 in 2024, then retreated by 12.37% to $352075.0 in 2025.
  • Per Business Quant data, the three most recent Notes Payables figures were $352075.0 in Q4 2025, $352075.0 in Q3 2025, and $352075.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn -
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn
10 Skinvisible 1.08 Mn 1.08 Mn 5,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 352,075.00
Sep 30, 2025 352,075.00
Jun 30, 2025 352,075.00
Mar 31, 2025 352,075.00
Sep 30, 2024 401,761.00
Jun 30, 2024 388,948.00
Mar 31, 2024 376,275.00
Dec 31, 2023 40,000.00
Sep 30, 2023 40,000.00
Jun 30, 2023 40,000.00
Mar 31, 2023 40,000.00
Dec 31, 2022 2.99 Mn
Sep 30, 2022 2.84 Mn
Jun 30, 2022 2.69 Mn
Mar 31, 2022 2.53 Mn
Dec 31, 2021 2.38 Mn
Sep 30, 2021 2.23 Mn
Jun 30, 2021 2.09 Mn
Mar 31, 2021 1.94 Mn
Dec 31, 2020 1.79 Mn